JF
Jeffrey S Farrow
See Remarks

Jeffrey S Farrow insider trades: Tarsus Pharmaceuticals (TARS) stock sales

See Remarks, Tarsus Pharmaceuticals Last trade Jun 16, 2026 51 Form 4 filings
$877K
Sold, last 12 months
1 sale
$0
Bought, last 12 months
0 buys
7
Open-market trades
since 2020
6
Companies
last trade 2026

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Jeffrey reports to the SEC

Open-market buys and sales

7 trades reported on SEC Form 4, newest first

DateStockTypeValue
Jun 16, 2026TARS↓ Sell$877K
Jun 17, 2025TARS↓ Sell$550K
Mar 20, 2025TARS↓ Sell$178K
Jun 18, 2024TARS↓ Sell$287K
Sep 1, 2022GBT↓ Sell$2.1M
Jul 13, 2020GBT↓ Sell$1.1M
Jun 9, 2020GBT↓ Sell$1.0M

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other TARS insiders

Open-market trades in the last 12 months

About Jeffrey S Farrow's insider trades

Jeffrey S Farrow is See Remarks at Tarsus Pharmaceuticals (TARS). Since Jun 9, 2020, Jeffrey has reported no open-market purchases and 7 sales worth $6.2M on SEC Form 4. In the last 12 months: 1 sale ($877K).

Their filings also include option exercises (27 filings), shares withheld for taxes (21 filings), grants and awards (19 filings), shares returned to the company (4 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every TARS insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.